USPTO serial 98130291
PHARMACY RESEARCH ORGANIZATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PHARMACY RESEARCH ORGANIZATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua G. Gigger
JOSHUA G. GIGGER STOEL RIVES LLP201 SOUTH MAIN STREET, SUITE 1200SALT LAKE CITY, UT 84111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising and promotion services; advertising and promotion of clinical trials; maintaining a registry of national and international databases in the field of clinical trials and healthcare; promoting the exchange of information and resources within the clinical trial and medical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making healthcare professional selection decisions; recruitment advertisement services, namely, posting of clinical trial notices for the purposes of providing clinical trial status, and recruiting and informing patients for participation in clinical trials; patient relationship management services; consulting services in the field of patient relationship management for clinical trials; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management to assist others with clinical research and clinical trials; business consulting services, namely, consulting in the field of clinical trials management; interactive record-keeping services for use in regulatory compliance in clinical trials by professionals in the medical field; business services provided in the field of clinical trials management, namely, data collection services for business purposes in the nature of extracting, summarizing, analyzing and validating information from medical records; business data compilation and tracking services for others, namely, interactive tracking of clinical trial subject enrollment, status and treatment | ACTIVE | — |
| 042 | Clinical trial services, namely, providing medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials; medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of clinical trials; consulting services for others in the field of design, planning, implementation, and management of clinical trials; consulting services in the fields of clinical trials; providing information about medical and scientific research; scientific research consulting in the field of clinical trials; technological planning and consulting services in the field of clinical trials; consulting services for others in the field of clinical trials, namely, consultation on conducting clinical trials; interactive medical clinical trial monitoring and alerts, namely, services for reminding clients of clinical trial parameters and treatment protocols for clinical trial purposes; clinical trial information services, namely, services featuring reminder alerts regarding clinical trial appointments scheduled for participants in clinical trials, and reporting of consumer authorized clinical testing results directly to the clinical trial participant; consultation and management services concerning the development, implementation, and management of clinical trials and scientific and medical research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 28, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 8, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2023 | NWAP | NEW APPLICATION ENTERED | — |